Requirements of Sterilizing Filtration Validation

Requirements of Sterilizing Filtration Validation

The landscape for manufacture of sterile medicinal products is evolving. Sterilizing filtration requirements are changing to reflect more complex fomulations. Expectations from regulatory authorities related to the evaluation of potential impurities or leachables for polymeric components with drug contact is also on the rise. We will share our updates on how we are working with end users to support them through these challenges.

 

Participants will learn about:

 

  • Regulatory and reference guidelines for filter validation and extractables and leachables evaluation
  • Typical filter validation tests
  • A risk assessment decision tree for E&L evaluation
  • A validation services process workflow

Speaker

 

 

Elisabeth Rizzo

Validation Project Manager

(Scientist II)

Elisabeth is a project manager within the European Validation team, supporting customers to document their Pall filter and single-use technology validation, to ensure their sterile manufacturing process will perform as intended in alignment with GMP requirements and industry guidelines.

Learn how Pall's Accelerator Validation Services Can Support You on Your Validation Journey

Download the brochure to read about Pall's depth of validation expertise, consultancy services, testing capabilities and analytical methods

더 Biotech Webinars
Our webinars keep you informed on the latest products and technologies, current industry topics, the latest trends and a range of innovations and solutions to help continuously improve your processes.
October 2021
Integrity Assurance for Single-Use Systems: An End-User’s Perspective

Biotech | Pall Corporation 웨비나 시리즈

Integrity Assurance for Single-Use Systems An End-User’s Perspective

 

What should you consider when building an integrity control strategy for your single-use systems (SUS)? How do you overcome application challenges?

 

Join leading industry experts Charlotte Masy of GSK and Patrick Evrard from Pall Corporation to gain insights and answers in this webinar from BioPharma Asia on integrity Assurance for Single-Use Systems, an End-User’s Perspective. They will present several case studies to show how integrity concerns can be practically addressed for cGMP manufacturing applications and the results observed a few years on. 

 

Attendees will learn about:

 

  • The latest regulatory requirements for integrity assurance of SUS
  • The different technologies available to control integrity of SUS
  • Key parameters that affect integrity measurements

 

Register now for this webinar from industry experts on October 6.

 

시청